Portal de Periódicos da CAPES

Urinary Tract Infections: What’s New?

2002; Lippincott Williams & Wilkins; Volume: 168; Issue: 6 Linguagem: Inglês

10.1016/s0022-5347(05)64145-6

1527-3792

John N. Krieger,

Urinary Bladder and Prostate Research

No AccessJournal of UrologyCLINICAL UROLOGY: Review Article1 Dec 2002Urinary Tract Infections: What’s New? JOHN N. KRIEGER JOHN N. KRIEGERJOHN N. KRIEGER More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)64145-6AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: This review provides practicing urologists with important basic information about urinary tract infections (UTIs) that can be applied to everyday clinical problems. Materials and Methods: A review is presented of provocative and controversial concepts in the current literature. Results: Bacterial virulence mechanisms are critical for overcoming the normal host defenses. Increasing antimicrobial resistance of uropathogens has led to reconsideration of traditional treatment recommendations in many areas. For effective patient management the first issue is to define complicating urological factors. Managing complicated urinary tract infections, particularly in urology, is determined by clinical experience to define the pertinent anatomy and to determine the optimal interventions. New clinical data are summarized on UTIs in long-term care patients, behavioral risks for UTI in healthy women and anatomical differences associated with an increased risk for UTI. The rationale is presented for UTI prophylaxis using cranberry juice, immunization and bacterial interference. Current treatment trends for UTI include empiric therapy (without urine culture and sensitivity testing), short-course therapy, patient-administered (self-start) therapy and outpatient therapy for uncomplicated pyelonephritis. Conclusions: Recommendations for treating patients with UTIs have changed based on basic science and clinical experience. References 1 : Secreted proteins and other features specific to uropathogenic Escherichia coli. J Infect Dis2001; 183: S32. Google Scholar 2 : Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis2000; 181: 261. Google Scholar 3 : Clonal relationships and extended virulence genotypes among Escherichia coli isolates from women with a first or recurrent episode of cystitis. J Infect Dis2001; 183: 1508. Google Scholar 4 : Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections. J Infect Dis2001; 183: S36. Google Scholar 5 : The role of P fimbriae for colonization and host response induction in the human urinary tract. J Infect Dis2001; 183: S43. Google Scholar 6 : The globoseries glycosphingolipid sialosyl galactosyl globoside is found in urinary tract tissues and is a preferred binding receptor in vitro for uropathogenic Escherichia coli expressing pap-encoded adhesins. Infect Immun1998; 66: 3856. Google Scholar 7 : Host factors in susceptibility to urinary tract infections. Adv Exp Med Biol1999; 462: 351. Google Scholar 8 : Pathogenicity islands of uropathogenic E. coli and evolution of virulence. Adv Exp Med Biol2000; 485: 25. Google Scholar 9 : Pathogenic diversity of Escherichia coli and the emergence of ‘exotic’ islands in the gene stream. Vet Res1999; 30: 157. Google Scholar 10 : Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and catheter-associated bacteriuria and from fecal samples. Infect Immun1998; 66: 4411. Google Scholar 11 : Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis1999; 29: 745. Google Scholar 12 : Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA1999; 281: 736. Google Scholar 13 : Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis2001; 33: 89. Google Scholar 14 : Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med2001; 135: 41. Google Scholar 15 : Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA2000; 283: 1583. Google Scholar 16 : Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli. Eur J Clin Microbiol Infect Dis1999; 18: 503. Google Scholar 17 : Molecular epidemiology of multi-resistant Escherichia coli. J Hosp Infect1999; 43: 39. Google Scholar 18 : Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998). J Antimicrob Chemother2000; 45: 295. Google Scholar 19 : Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother2000; 46: 223. Google Scholar 20 : Vancomycin-resistant enterococci: mechanisms and clinical observations. Clin Infect Dis2001; 33: 210. Google Scholar 21 : Vancomycin-resistant enterococcal infections. N Engl J Med2000; 342: 710. Google Scholar 22 : Linezolid: an oxazolidinone antimicrobial agent. Clin Ther2001; 23: 356. Google Scholar 23 : Linezolid—a review of the first oxazolidinone. Expert Opin Pharmacother2001; 2: 293. Google Scholar 24 : Gentamicin for the practicing urologist: review of efficacy, single daily dosing and “switch” therapy. J Urol2000; 163: 1076. Link, Google Scholar 25 : Infection control in long-term care facilities. Clin Infect Dis2000; 31: 752. Google Scholar 26 : Urinary tract pathogens in complicated infection and in elderly individuals. J Infect Dis2001; 183: S5. Google Scholar 27 : Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol2001; 22: 120. Google Scholar 28 : Urinary tract infection in long-term-care facility residents. Clin Infect Dis2000; 31: 757. Google Scholar 29 : Asymptomatic bacteriuria—important or not?. N Engl J Med2000; 343: 1037. Google Scholar 30 : Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am1997; 11: 647. Google Scholar 31 : Urinary tract infections in long-term-care facilities. Infect Control Hosp Epidemiol2001; 22: 167. Google Scholar 32 : Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am1997; 11: 551. Google Scholar 33 : Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents2001; 17: 343. Google Scholar 34 : Pathogenesis and management of recurrent urinary tract infections in women. World J Urol1999; 17: 415. Google Scholar 35 : Risk factors for recurrent urinary tract infection in young women. J Infect Dis2000; 182: 1177. Google Scholar 36 : Effects of vaginal intercourse with and without a condom on vaginal flora and vaginal epithelium. J Infect Dis2001; 183: 913. Google Scholar 37 : Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. J Infect Dis2000; 181: 595. Google Scholar 38 : Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infections. Clin Infect Dis1999; 29: 1600. Google Scholar 39 : Inhibition of bacterial adherence by cranberry juiaaa potential use for the treatment of urinary tract infections. J Urol1984; 131: 1013. Abstract, Google Scholar 40 : Potential preventive strategies and therapies in urinary tract infection. World J Urol1999; 17: 359. Google Scholar 41 : Role of bacterial lectins in urinary tract infections. Molecular mechanisms for diversification of bacterial surface lectins. Adv Exp Med Biol2000; 485: 183. Google Scholar 42 : Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA1994; 271: 751. Google Scholar 43 : New support for a folk remedy: cranberry juice reduces bacteriuria and pyuria in elderly women. Nutr Rev1994; 52: 168. Google Scholar 44 : Cranberry juice and urinary-tract health: science supports folklore. Nutrition2000; 16: 684. Google Scholar 45 : Cranberry juice and urinary tract infections: what is the evidence?. Urology2001; 57: 407. Google Scholar 46 : Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001; 322: 1571. Google Scholar 47 : Untreated asymptomatic bacteriuria in girls: I—stability of urinary isolates. BMJ1989; 298: 853. Google Scholar 48 : Untreated asymptomatic bacteriuria in girls: II—effect of phenoxymethylpenicillin and erythromycin given for intercurrent infections. BMJ1989; 298: 856. Google Scholar 49 : Significance of asymptomatic bacteriuria in spinal cord injury patients on condom catheter. J Urol1990; 143: 979. Link, Google Scholar 50 : Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol2000; 163: 872. Link, Google Scholar 51 : FIMCH vaccine against a pyelonephritic E. coli. J Urol2001; 165: 6. abstract 27. Google Scholar 52 : Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial. J Urol1997; 157: 2049. Link, Google Scholar 53 : Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial. J Infect Dis2001; 183: S81. Google Scholar 54 : Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J Clin Invest1997; 100: 1123. Google Scholar 55 : Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis2000; 181: 774. Google Scholar 56 : Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. J Infect Dis2001; 183: S84. Google Scholar 57 Bichler, K.H.: Urovaxom-a metaanalysis. Presented at 7th International Symposium on Clinical Evaluation of Drug Efficacy in UTI. International Society of Chemotherapy Commission for Urinary Tract Infections, Amsterdam, The Netherlands, July 1–3, 2001. Google Scholar 58 : Pathophysiology of bacterial cystitis. Adv Exp Med Biol1999; 462: 325. Google Scholar 59 : Effects of recent sexual activity and use of a diaphragm on the vaginal microflora. Clin Infect Dis1994; 19: 274. Google Scholar 60 : A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med2000; 343: 992. Google Scholar 61 : Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis2000; 30: 152. Google Scholar 62 : Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis1999; 28: 723. Google Scholar 63 : A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol1999; 180: 1072. Google Scholar 64 : Recurrent urinary tract infection in women. Int J Antimicrob Agents2001; 17: 259. Google Scholar 65 : Postmenopausal women with recurrent UTI. Int J Antimicrob Agents2001; 17: 269. Google Scholar 66 : Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis2001; 183: S74. Google Scholar 67 : Complicated urinary tract infections. Infect Dis Clin North Am1997; 11: 583. Google Scholar 68 : When to do culture in urinary tract infections. Int J Antimicrob Agents1999; 11: 253. Google Scholar 69 : Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies. J Fam Pract1997; 44: 49. Google Scholar 70 : Management of urinary tract infection in general practiaaa a cost-effectiveness analysis. Br J Gen Pract2000; 50: 635. Google Scholar 71 : Empiric treatment of uncomplicated urinary tract infections. Ann Pharmacother1998; 32: 1231. Google Scholar 72 : Treatment options for acute uncomplicated cystitis in adults. J Antimicrob Chemother2000; 46: 23. Google Scholar 73 : Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol1999; 161: 207. Link, Google Scholar 74 : Which fluoroquinolones are suitable for the treatment of urinary tract infections?. Int J Antimicrob Agents2001; 17: 331. Google Scholar 75 : A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother1999; 43: 67. Google Scholar 76 : Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. German Ciprofloxacin UTI Study Group. Int J Antimicrob Agents1999; 11: 133. Google Scholar 77 : Comparative study of single-dose and three-day therapy for acute uncomplicated cystitis. Hinyokika Kiyo1999; 45: 85. Google Scholar 78 : A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med1999; 106: 292. Google Scholar 79 : Sub-MIC ciprofloxacin effect on fimbrial production by uropathogenic Escherichia coli strains. J Chemother1999; 11: 357. Google Scholar 80 : Short-term therapy of acute uncomplicated cystitis. Curr Opin Urol1999; 9: 57. Google Scholar 81 : Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob Agents Chemother1991; 35: 1479. Google Scholar 82 : Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann Intern Med1985; 102: 302. Google Scholar 83 : Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med1999; 159: 53. Google Scholar 84 : Single-dose/short-term therapy in children and in pregnant women. Infection1994; 22: S47. Google Scholar 85 : Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis. Clin Nephrol1996; 46: 183. Google Scholar 86 : Jewish medicine and the University of Padua: contribution of the Padua graduate Toviah Cohen to nephrology. Am J Nephrol1999; 19: 213. Google Scholar 87 : The Peri ouron treatise of Stephanus of Athens: Byzantine uroscopy of the 6th–7th centuries AD. Am J Nephrol1997; 17: 228. Google Scholar 88 : Uroscopy in Byzantium. Am J Nephrol1997; 17: 222. Google Scholar 89 : Measurement of pyuria and its relation to bacteriuria. Am J Med1983; 75: 53. Google Scholar 90 : Diagnosis of urinary tract infection by urine microscopy using a disposable counting chamber. Scand J Clin Lab Invest1993; 53: 705. Google Scholar 91 : Urine microscopy on a counting chamber for diagnosis of urinary infection. Acta Paediatr Jpn1995; 37: 27. Google Scholar 92 : Reliability of pyuria detection method. Infection1994; 22: S36. Google Scholar From the Department of Urology, University of Washington School of Medicine, Seattle, Washington© 2002 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited ByMossanen M, Calvert J, Holt S, James A, Wright J, Harper J, Krieger J and Gore J (2018) Overuse of Antimicrobial Prophylaxis in Community Practice UrologyJournal of Urology, VOL. 193, NO. 2, (543-547), Online publication date: 1-Feb-2015.Griebling T (2018) Re: Challenges in Assessing Nursing Home Residents with Advanced Dementia for Suspected Urinary Tract InfectionsJournal of Urology, VOL. 190, NO. 6, (2104-2105), Online publication date: 1-Dec-2013. Volume 168Issue 6December 2002Page: 2351-2358 Advertisement Copyright & Permissions© 2002 by American Urological Association, Inc.Keywordsdrug resistance, microbialurinary tract infectionspyelonephritisimmunizationvirulenceMetricsAuthor Information JOHN N. KRIEGER More articles by this author Expand All Advertisement PDF DownloadLoading ...